SCHEMBL7003023

SCHEMBL7003023

OC1(c2ccc3[nH]ccc3c2)CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 7/20 0.50
SLC6A2 P23975 7/20 0.50
SLC6A4 P31645 7/20 0.50
SLC6A3 Q01959 7/20 0.50
USP2 O75604 1/20 0.46
GAA P10253 1/20 0.46
ALOX15 P16050 1/20 0.46
RAD51 Q06609 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KCNH2 Q12809 3/20 0.43
AHR P35869 3/20 0.42
NR4A2 P43354 2/20 0.42
CYP2A6 P11509 2/20 0.42
F7 P08709 1/20 0.42
LTA4H P09960 1/20 0.42
F3 P13726 1/20 0.42
HDAC1 Q13547 1/20 0.40
F2 P00734 1/20 0.40
EPHX1 P07099 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882959 0.85 SLC6A2 (0.60) CYP2D6SLC6A2SLC6A4SLC6A3USP2
SCHEMBL7001055 0.81 SLC6A2 (0.49) CYP2D6SLC6A2SLC6A4SLC6A3USP2
SCHEMBL30055150 0.74 PRKAB2 (0.59) AHR
SCHEMBL29945431 0.72 HRH3 (0.37) SLC6A2SLC6A4SLC6A3
SCHEMBL1465074 0.72 SLC6A2 (0.49) CYP2D6SLC6A2SLC6A4SLC6A3USP2
SCHEMBL5361306 0.72 SLC6A4 (0.57) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL27957976 0.71 PRKAB2 (0.59) CYP2D6SLC6A2SLC6A4SLC6A3HDAC1
SCHEMBL31748630 0.71 PRKAB2 (0.59) CYP2D6SLC6A2SLC6A4SLC6A3AHR
SCHEMBL29773124 0.71 SLC6A2 (0.48) CYP2D6SLC6A2SLC6A4SLC6A3USP2
SCHEMBL5114241 0.71 SLC6A2 (0.48) CYP2D6SLC6A2SLC6A4SLC6A3USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562809-B1 Contraction of coronary arteries may be mediated by its stimulation of the 5-HT1B (formerly 5-HT1D beta); compounds selective for a 5-HT1D receptor NPS ALLELIX CORP. (CA) 2003-05-13 US disclosed
EP-1114049-B1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS NPS ALLELIX CORP (CA) 2003-03-19 EP disclosed
EP-1114049-A1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS NPS Allelix Corp. (CA) 2001-07-11 EP disclosed
WO-2000017198-A1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-03-30 WO disclosed